Exploratory Study of Neoadjuvant Treatment of HER2-positive Breast Cancer With Py in Combination With HP
Clinical trial NCT04929548 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04929548
- Sponsor
- Wuhan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-05
- Primary completion
- 2022-01-05
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.